A surgical mouse model of neonatal right ventricular outflow tract obstruction by pulmonary artery banding
Copyright © 2023 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved..
BACKGROUD: Diseased animal models play an extremely important role in preclinical research. Lacking the corresponding animal models, many basic research studies cannot be carried out, and the conclusions obtained are incomplete or even incorrect. Right ventricular (RV) outflow tract (RVOT) obstruction leads to RV pressure overload (PO) and reduced pulmonary blood flow (RPF), which are 2 of the most important pathophysiological characteristics in pediatric cardiovascular diseases and seriously affect the survival rate and long-term quality of life of many children. Due to the lack of a neonatal mouse model for RVOT obstruction, it is largely unknown how RV PO and RPF regulate postnatal RV and pulmonary development. The aim of this study was to construct a neonatal RVOT obstruction mouse model.
METHODS AND RESULTS: Here, we first introduced a neonatal mouse model of RVOT obstruction by pulmonary artery banding (PAB) on postnatal day 1. PAB induced neonatal RVOT obstruction, RV PO, and RPF. Neonatal RV PO induced cardiomyocyte proliferation, and neonatal RPF induced pulmonary dysplasia, the 2 features that are not observed in adult RVOT obstruction. As a result, PAB neonates exhibited overall developmental dysplasia, a sign similar to that of children with RVOT obstruction.
CONCLUSIONS: Because many pediatric cardiovascular diseases are associated with RV PO and RPF, the introduction of a neonatal mouse model of RVOT obstruction may greatly enhance our understanding of these diseases and eventually improve or save the lives of many children.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
---|---|
Enthalten in: |
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation - 43(2024), 3 vom: 22. Feb., Seite 496-507 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Li, Debao [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cardiomyocyte proliferation |
---|
Anmerkungen: |
Date Completed 26.02.2024 Date Revised 26.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.healun.2023.10.009 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363326588 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM363326588 | ||
003 | DE-627 | ||
005 | 20240229154515.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.healun.2023.10.009 |2 doi | |
028 | 5 | 2 | |a pubmed24n1306.xml |
035 | |a (DE-627)NLM363326588 | ||
035 | |a (NLM)37839791 | ||
035 | |a (PII)S1053-2498(23)02074-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Li, Debao |e verfasserin |4 aut | |
245 | 1 | 2 | |a A surgical mouse model of neonatal right ventricular outflow tract obstruction by pulmonary artery banding |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.02.2024 | ||
500 | |a Date Revised 26.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved. | ||
520 | |a BACKGROUD: Diseased animal models play an extremely important role in preclinical research. Lacking the corresponding animal models, many basic research studies cannot be carried out, and the conclusions obtained are incomplete or even incorrect. Right ventricular (RV) outflow tract (RVOT) obstruction leads to RV pressure overload (PO) and reduced pulmonary blood flow (RPF), which are 2 of the most important pathophysiological characteristics in pediatric cardiovascular diseases and seriously affect the survival rate and long-term quality of life of many children. Due to the lack of a neonatal mouse model for RVOT obstruction, it is largely unknown how RV PO and RPF regulate postnatal RV and pulmonary development. The aim of this study was to construct a neonatal RVOT obstruction mouse model | ||
520 | |a METHODS AND RESULTS: Here, we first introduced a neonatal mouse model of RVOT obstruction by pulmonary artery banding (PAB) on postnatal day 1. PAB induced neonatal RVOT obstruction, RV PO, and RPF. Neonatal RV PO induced cardiomyocyte proliferation, and neonatal RPF induced pulmonary dysplasia, the 2 features that are not observed in adult RVOT obstruction. As a result, PAB neonates exhibited overall developmental dysplasia, a sign similar to that of children with RVOT obstruction | ||
520 | |a CONCLUSIONS: Because many pediatric cardiovascular diseases are associated with RV PO and RPF, the introduction of a neonatal mouse model of RVOT obstruction may greatly enhance our understanding of these diseases and eventually improve or save the lives of many children | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Tetralogy of Fallot | |
650 | 4 | |a cardiomyocyte proliferation | |
650 | 4 | |a congenital heart disease | |
650 | 4 | |a pressure overload | |
650 | 4 | |a pulmonary dysplasia | |
650 | 4 | |a pulmonary hypertension | |
650 | 4 | |a right ventricle | |
700 | 1 | |a Hong, Haifa |e verfasserin |4 aut | |
700 | 1 | |a Li, Minghui |e verfasserin |4 aut | |
700 | 1 | |a Xu, Xiuxia |e verfasserin |4 aut | |
700 | 1 | |a Wang, Shoubao |e verfasserin |4 aut | |
700 | 1 | |a Xiao, Yingying |e verfasserin |4 aut | |
700 | 1 | |a Zheng, Sixie |e verfasserin |4 aut | |
700 | 1 | |a Wang, Zheng |e verfasserin |4 aut | |
700 | 1 | |a Yan, Yi |e verfasserin |4 aut | |
700 | 1 | |a Chen, Hao |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Chunxia |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Hao |e verfasserin |4 aut | |
700 | 1 | |a Sun, Qi |e verfasserin |4 aut | |
700 | 1 | |a Ye, Lincai |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation |d 1993 |g 43(2024), 3 vom: 22. Feb., Seite 496-507 |w (DE-627)NLM012612367 |x 1557-3117 |7 nnns |
773 | 1 | 8 | |g volume:43 |g year:2024 |g number:3 |g day:22 |g month:02 |g pages:496-507 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.healun.2023.10.009 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 43 |j 2024 |e 3 |b 22 |c 02 |h 496-507 |